ArticleContemporary clinical trials communications2026
Protocol for a randomized controlled trial of a cognitive-behavioral therapy-based smoking cessation intervention in incarcerated individuals: The PRISANTABAC Study.
Article in Contemporary clinical trials communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Smoking prevalence in French prisons exceeds 70%, far higher than in the general population. Few rigorous smoking cessation interventions have been evaluated in correctional settings, and existing studies show substantial heterogeneity and high risk of bias. Cognitive-behavioural therapy (CBT) is effective in the general population but has rarely been adapted to prison contexts. The PRISANTABAC trial addresses this gap by evaluating a brief group-based CBT intervention for smoking cessation in a French prison. Objectives: To evaluate the effectiveness of group CBT, compared with a health education intervention and a wait-list control, on smoking abstinence at 1-month (M1) and 3-month (M3) follow-ups, and to explore individual predictors of abstinence. Methods: PRISANTABAC is a three-arm randomized controlled trial conducted in a French correctional facility. Participants are randomized (1:1:1) to a three-session CBT group, a health education group, or a wait-list control. The primary outcome is biochemically validated 7-day point prevalence abstinence at M3 (0 cigarettes/day; expired CO < 8 ppm); abstinence at M1 is a key secondary outcome. Secondary outcomes include nicotine dependence, craving, motivation to quit, self-efficacy, and cigarettes smoked per day. Abstinence will be analysed using logistic regression, and repeated continuous outcomes using linear mixed-effects models. Analyses will follow the intention-to-treat principle. Discussion: This trial will provide the first rigorously designed evaluation of a brief group-based CBT smoking cessation intervention in a French prison setting and is expected to inform the development of evidence-based cessation interventions adapted to correctional environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.